CST, 60887S, Dorsomorphin (Compound C)

Product Usage Information
Dorsomorphin (Compound C) is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 1.25 ml of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.
Storage
Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.
Background
Dorsomorphin (Compound C) is a potent and reversible AMP-activated protein kinase (AMPK) inhibitor that competes with ATP in the absence of AMP with a K value of 109 nM (1). This small compound is selective, displaying no significant inhibition of other kinases inclusive of ZAPK, SYK, PKCθ, PKA, and JAK3 (1). Research has shown that Dorsomorphin (Compound C) inhibits tumor cell proliferation and induces apoptosis through mechanisms independent of the AMPK pathway (2). This compound inhibits the effects that AICAR and metformin have on inactivating acetyl-CoA carboxylase (ACC) and selectively inhibits the BMP type I receptors ALK2, ALK3, and ALK6 (1,3).Â
Alternate Names
6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-pyrazolo[1,5-a]pyrimidine; BML-275; Compound C; Dorsomorphin; Dorsomorphin dihydrochloride